Mon, September 10, 2018

by: WOPRAI

Ralph Giacobbe Downgraded (UNH) to Hold on, Sep 10th, 2018

by: WOPRAI

Peter Heckmann Maintained (SSNC) at Hold with Decreased Target to $60 on, Sep 10th, 2018

by: WOPRAI

Ashish Sabadra Upgraded (SSNC) to Strong Buy on, Sep 10th, 2018

by: WOPRAI

Michael Matson Upgraded (TFX) to Strong Buy and Increased Target to $300 on, Sep 10th, 2018

by: WOPRAI

David Tarantino Downgraded (TXRH) to Hold on, Sep 10th, 2018

by: WOPRAI

Nick Setyan Downgraded (TXRH) to Hold on, Sep 10th, 2018

by: WOPRAI

Jordan Sadler Maintained (DOC) at Buy with Increased Target to $18 on, Sep 10th, 2018

by: WOPRAI

Jeffrey Spector Maintained (SPG) at Strong Buy with Increased Target to $203 on, Sep 10th, 2018

by: WOPRAI

Jeffrey Hung Initiated (VYGR) at Hold and Held Target at $27 on, Sep 10th, 2018

by: WOPRAI

Dane Leone Initiated (VYGR) at Strong Buy and Held Target at $32 on, Sep 10th, 2018

Fri, September 7, 2018

by: WOPRAI

Dan Dolev Maintained (ARMK) at Strong Buy with Increased Target to $50 on, Sep 7th, 2018

by: WOPRAI

Raimo Lenschow Maintained (APPN) at Sell with Increased Target to $29 on, Sep 7th, 2018

by: WOPRAI

Jeff Van Sinderen Maintained (ZUMZ) at Strong Buy with Increased Target to $34 on, Sep 7th, 2018

by: WOPRAI

Michael Graham Maintained (Z) at Strong Buy with Decreased Target to $60 on, Sep 7th, 2018

by: WOPRAI

Michael Graham Maintained (ZG) at Strong Buy with Decreased Target to $60 on, Sep 7th, 2018

by: WOPRAI

Timothy Wojs Upgraded (AYI) to Buy on, Sep 7th, 2018

by: WOPRAI

Vivek Arya Upgraded (AVGO) to Strong Buy on, Sep 7th, 2018

by: WOPRAI

Craig Ellis Maintained (AVGO) at Hold and Held Target at $25 on, Sep 7th, 2018

by: WOPRAI

Andrew Kaplowitz Downgraded (ATKR) to Hold on, Sep 7th, 2018

by: WOPRAI

Faisel Khan Maintained (VLO) at Strong Buy with Increased Target to $134 on, Sep 7th, 2018

Thu, September 6, 2018

by: WOPRAI

Alethia Young Initiated (SRPT) at Buy and Held Target at $178 on, Sep 6th, 2018

by: WOPRAI

Domingos Falavina Upgraded (BSAC) to Buy on, Sep 6th, 2018

by: WOPRAI

Jason Mills Maintained (TCMD) at Strong Buy with Increased Target to $75 on, Sep 6th, 2018

by: WOPRAI

Adam Baumgarten Maintained (SWK) at Buy with Decreased Target to $175 on, Sep 6th, 2018

by: WOPRAI

Adam Baumgarten Maintained (BLD) at Hold with Decreased Target to $67 on, Sep 6th, 2018

by: WOPRAI

Kenneth Herbert Maintained (AVAV) at Hold with Increased Target to $80 on, Sep 6th, 2018

by: WOPRAI

Brad Zelnick Maintained (ZS) at Buy with Increased Target to $46 on, Sep 6th, 2018

by: WOPRAI

Melissa Franchi Maintained (ZS) at Hold with Increased Target to $41 on, Sep 6th, 2018

by: WOPRAI

Kenneth Worthington Downgraded (BEN) to Sell and Decreased Target to $29 on, Sep 6th, 2018

by: WOPRAI

Keay Nakae Maintained (ARWR) at Strong Buy with Increased Target to $25 on, Sep 6th, 2018

Wed, September 5, 2018

by: WOPRAI

Nicole Deblase Initiated (AGCO) at Strong Buy and Held Target at $79 on, Sep 5th, 2018

by: WOPRAI

Nicole Deblase Initiated (CAT) at Strong Buy and Held Target at $177 on, Sep 5th, 2018

by: WOPRAI

Laurent Vasilescu Maintained (CAL) at Buy with Increased Target to $42 on, Sep 5th, 2018

by: WOPRAI

Tom Forte Maintained (AMZN) at Strong Buy with Increased Target to $123 on, Sep 5th, 2018

by: WOPRAI

Tom Forte Maintained (AAPL) at Strong Buy with Increased Target to $66 on, Sep 5th, 2018

by: WOPRAI

Katy Huberty Maintained (AAPL) at Buy with Increased Target to $61 on, Sep 5th, 2018

by: WOPRAI

Nicole Deblase Initiated (URI) at Hold and Held Target at $158 on, Sep 5th, 2018

by: WOPRAI

Seth Sigman Maintained (AZO) at Buy with Increased Target to $810 on, Sep 5th, 2018

by: WOPRAI

Richard Davis Maintained (WDAY) at Strong Buy with Increased Target to $175 on, Sep 5th, 2018

Tue, September 4, 2018

by: WOPRAI

Craig Moffett Downgraded (VZ) to Hold on, Sep 4th, 2018

by: WOPRAI

Amir Rozwadowski Downgraded (VZ) to Hold and Decreased Target to $50 on, Sep 4th, 2018

by: WOPRAI

Brent Bracelin Maintained (BAND) at Buy with Increased Target to $64 on, Sep 4th, 2018

by: WOPRAI

Christopher O"Connell Initiated (AMAL) at Hold and Held Target at $19 on, Sep 4th, 2018

by: WOPRAI

Michael Walkley Maintained (AAPL) at Strong Buy with Increased Target to $63 on, Sep 4th, 2018

by: WOPRAI

Kimberly Greenberger Maintained (ANF) at Sell with Increased Target to $14 on, Sep 4th, 2018

by: WOPRAI

James Faucette Downgraded (ANET) to Hold on, Sep 4th, 2018

by: WOPRAI

Devin McDermott Maintained (APA) at Sell with Decreased Target to $41 on, Sep 4th, 2018

by: WOPRAI

James Sheehan Upgraded (ALB) to Strong Buy and Increased Target to $115 on, Sep 4th, 2018

Keay Nakae Maintained (ARWR) at Strong Buy with Increased Target to $25 on, Sep 6th, 2018

Keay Nakae of Chardan Capital, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy with Increased Target from $18 to $25 on, Sep 6th, 2018.

Keay has made no other calls on ARWR in the last 4 months.



There is 1 other peer that has a rating on ARWR. Out of the 1 peers that are also analyzing ARWR, 0 agree with Keay's Rating of Hold.



This is the rating of the analyst that currently disagrees with Keay

  • Elemer Piros of "Cantor Fitzgerald" Upgraded from Hold to Buy on, Wednesday, May 9th, 2018